EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | 2C25H34FN3O2.C4H6O6 |
| Net Charge | 0 |
| Average Mass | 1005.214 |
| Monoisotopic Mass | 1004.54345 |
| SMILES | CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O |
| InChI | InChI=1S/2C25H34FN3O2.C4H6O6/c2*1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21;5-1(3(7)8)2(6)4(9)10/h2*4-11,19,23H,12-18H2,1-3H3,(H,27,30);1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1 |
| InChIKey | RGSULKHNAKTFIZ-CEAXSRTFSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. 5-hydroxytryptamine 2A receptor inverse agonist An inverse agonist that binds to the same receptor as a 5-hydroxytryptamine 2A receptor agonist, but which induces a pharmacological response opposite to that agonist. |
| Applications: | serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pimavanserin tartrate (CHEBI:133014) has part pimavanserin(1+) (CHEBI:133020) |
| pimavanserin tartrate (CHEBI:133014) has role 5-hydroxytryptamine 2A receptor inverse agonist (CHEBI:133016) |
| pimavanserin tartrate (CHEBI:133014) has role antipsychotic agent (CHEBI:35476) |
| pimavanserin tartrate (CHEBI:133014) has role serotonergic antagonist (CHEBI:48279) |
| pimavanserin tartrate (CHEBI:133014) is a tartrate salt (CHEBI:50562) |
| IUPAC Names |
|---|
| bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate |
| bis{N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea} (2R,3R)-2,3-dihydroxybutanedioate |
| Synonyms | Source |
|---|---|
| ACP 103 | ChemIDplus |
| ACP-103 | ChemIDplus |
| Bis(1-(4-Fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate | ChemIDplus |
| pimavanserin hemitartrate | ChEBI |
| Brand Name | Source |
|---|---|
| Nuplazid | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| D08969 | KEGG DRUG |
| NZ541146 | Patent |
| Pimavanserin | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:10410569 | Reaxys |
| CAS:706782-28-7 | ChemIDplus |
| CAS:706782-28-7 | KEGG DRUG |
| Citations |
|---|